- 23 September 2011
- journal article
- other
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 170 (11) , 1365-1367
Abstract
Barth syndrome (OMIM #302060) (BTHS) is an X-linked disorder of lipid metabolism characterized by skeletal myopathy, neutropenia, growth delay, and cardiomyopathy. It is caused by mutations in the tafazzin gene (TAZ), which lead to decreased production of an enzyme required to produce cardiolipin, a component of the inner mitochondrial membrane necessary for proper functioning of the electron transport chain. The most common initial presentation of BTHS is significant heart failure due to cardiomyopathy, which is the main cause of death in infancy or childhood. On the other hand, some patients have limited clinical features of BTHS. These patients may be overlooked or misdiagnosed with unclassified congenital myopathy, especially when heart failure is not clinically significant. However, these patients could also develop significant heart failure or life-threatening arrhythmias during or even after childhood. Heart failure in BTHS is often responsive to standard medical therapy, indicating early diagnosis is critical. Diagnostic clues of BTHS in the subclinical stage of heart failure include family histories, findings of lipid storage myopathy in the skeletal muscle biopsy, and elevated plasma brain natriuretic peptide levels. The genetic analysis of TAZ is the only confirmatory method for the diagnosis of BTHS. Conclusion: physicians should be aware of the possibility of this disease and carry out genetic studies when it is considered.Keywords
This publication has 24 references indexed in Scilit:
- Lipid Storage MyopathyCurrent Neurology and Neuroscience Reports, 2010
- Barth syndrome: an X‐linked cause of fetal cardiomyopathy and stillbirthPrenatal Diagnosis, 2010
- Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography–mass spectrometry as a diagnostic test for Barth syndromeAnalytical Biochemistry, 2009
- Cardiac and Clinical Phenotype in Barth SyndromePediatrics, 2006
- Cardiolipin metabolism and Barth SyndromeProgress in Lipid Research, 2006
- Deficiency of tetralinoleoyl‐cardiolipin in Barth syndromeAnnals of Neurology, 2002
- X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome) (MIM 302060)Journal of Inherited Metabolic Disease, 1999
- A novel X-linked gene, G4.5. is responsible for Barth syndromeNature Genetics, 1996
- Barth syndrome: Clinical features and confirmation of gene localisation to distal Xq28American Journal of Medical Genetics, 1993
- X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduriaThe Journal of Pediatrics, 1991